Current price – 379
Target – 800
Time frame – 1 year
This one is really solid bet in pharma sector giving consistent performance year after year, this one is a must have in the pharma pack.
An R&D driven organization, Bilcare Research focuses on developing cutting-edge solutions that enable the pharmaceutical industry to realize significant qualitative and measurable cost and time benefits in the 'drug discovery to market' value chain.
Bilcare Research has a global footprint with modern manufacturing and R&D plants located across U.S., Europe, India and Singapore. We work with leading pharmaceutical companies across the globe to address their challenges. This includes not only bolstering the drug discovery pipeline through innovative products, processes and services, but also improving the efficacy of pharmaceuticals and drug delivery through innovative solutions in packaging. Our novel brand protection and management technologies aim to ensure that safe and genuine medicines reach the hands of consumers.
Valuations - PE -10, DE - .56, Book value - 344. Amazing management, 1% dividend yield.
This one is a must buy, don't miss out on such a wonderful opportunity at such a price.
Thanks.
Bilcare Research has a global footprint with modern manufacturing and R&D plants located across U.S., Europe, India and Singapore. We work with leading pharmaceutical companies across the globe to address their challenges. This includes not only bolstering the drug discovery pipeline through innovative products, processes and services, but also improving the efficacy of pharmaceuticals and drug delivery through innovative solutions in packaging. Our novel brand protection and management technologies aim to ensure that safe and genuine medicines reach the hands of consumers.
Valuations - PE -10, DE - .56, Book value - 344. Amazing management, 1% dividend yield.
This one is a must buy, don't miss out on such a wonderful opportunity at such a price.
Thanks.
No comments:
Post a Comment